Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
Endosense, Siemens Healthcare enter joint catheter ablation development project

Endosense, Siemens Healthcare enter joint catheter ablation development project

BIOTRONIK announces FDA IDE approval and first patient enrollment for TOCCASTAR clinical trial

BIOTRONIK announces FDA IDE approval and first patient enrollment for TOCCASTAR clinical trial

Patients on dialysis may face risk of death from atrial fibrillation: Study

Patients on dialysis may face risk of death from atrial fibrillation: Study

Endosense initiates enrollment in TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation

Endosense initiates enrollment in TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation

Stereotaxis announces first successful cardiac ablation procedure with Vdrive robotic navigation system

Stereotaxis announces first successful cardiac ablation procedure with Vdrive robotic navigation system

Baylor Hamilton offers Arctic Front Cardiac CryoAblation Catheter system treatment for paroxysmal atrial fibrillation

Baylor Hamilton offers Arctic Front Cardiac CryoAblation Catheter system treatment for paroxysmal atrial fibrillation

nContact Surgical removes 'Surgical' from company name

nContact Surgical removes 'Surgical' from company name

J&JPRD submits New Drug Application to FDA for rivaroxaban

J&JPRD submits New Drug Application to FDA for rivaroxaban

Mayo Clinic uses Arctic Front Cardiac CryoAblation Catheter system for treating AF

Mayo Clinic uses Arctic Front Cardiac CryoAblation Catheter system for treating AF

Pico-Tesla commences placebo-controlled Magneceutical Therapy study for Alzheimer's disease

Pico-Tesla commences placebo-controlled Magneceutical Therapy study for Alzheimer's disease

Stereotaxis extends strategic partnership to distribute magnetic ablation catheters

Stereotaxis extends strategic partnership to distribute magnetic ablation catheters

Pico-Tesla announces expansion of Magneceutical Phase III trail for Parkinson's disease

Pico-Tesla announces expansion of Magneceutical Phase III trail for Parkinson's disease

Omega-3 fatty acids may reduce inflammation, disease symptoms and cartilage degeneration

Omega-3 fatty acids may reduce inflammation, disease symptoms and cartilage degeneration

Researchers to identify gene variants that cause ischemic stroke

Researchers to identify gene variants that cause ischemic stroke

Merck confirms plans for developing vernakalant drug for atrial fibrillation

Merck confirms plans for developing vernakalant drug for atrial fibrillation

New era for anticoagulant therapy

New era for anticoagulant therapy

Top ten advances in cardiovascular, stroke research in 2010

Top ten advances in cardiovascular, stroke research in 2010

FDA approves Medtronic's Arctic Front Cardiac CryoAblation Catheter system for drug refractory PAF

FDA approves Medtronic's Arctic Front Cardiac CryoAblation Catheter system for drug refractory PAF

Pico-Tesla commences pilot study of Magneceutical Therapy in fibromyalgia patients

Pico-Tesla commences pilot study of Magneceutical Therapy in fibromyalgia patients

DeCODE Genetics identify SNPs to derive PSA threshold for diagnosing prostrate cancer

DeCODE Genetics identify SNPs to derive PSA threshold for diagnosing prostrate cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.